News Focus
News Focus
Post# of 257580
Next 10
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: genisi post# 158701

Friday, 05/24/2013 2:00:50 PM

Friday, May 24, 2013 2:00:50 PM

Post# of 257580
Xarelto® (rivaroxaban) has been approved by the European Commission for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction or stroke) after an Acute Coronary Syndrome (ACS)

http://press.healthcare.bayer.com/en/press/news-details-page.php/15050/2013-0292

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today